Interestingly, studies in patients with metastatic melanoma have revealed overwhelming Th2-driven chronic inflammation [44], suggesting that the elimination of CD4 T cells could relieve major barriers to the generation of CD8 T cell immunity in these patients. Here, CD4 is linked to metastatic melanoma.